Oral hypoglycemic therapy and associated hypothyroidism.
D000092:Acetohexamide / Q000009:adverse effects; D000368:Aged; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007037:Hypothyroidism / Q000209:etiology*; D007049:Iatrogenic Disease; D007475:Ion Exchange Resins; D008297:Male; D008875:Middle Aged; D010629:Phenformin / Q000009:adverse effects; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000187:drug effects; D014042:Tolazamide / Q000009:adverse effects; D014044:Tolbutamide / Q000009:adverse effects; D014284:Triiodothyronine
D007004:Hypoglycemic Agents; D007475:Ion Exchange Resins; D014284:Triiodothyronine; D014044:Tolbutamide; D014042:Tolazamide; D010629:Phenformin; D000092:Acetohexamide